Cardiac arrest (CA) is the cessation of circulation to vital organs that can only be reversed with rapid and appropriate interventions. Sensor technologies for early detection and activation of the emergency medical system could enable rapid response to CA and increase the probability of survival. We conducted a systematic review to summarize the literature surrounding the performance of sensor technologies in detecting OHCA. We searched the academic and grey literature using keywords related to cardiac arrest, sensor technologies, and recognition/detection. We included English articles published up until June 6, 2022, including investigations and patent filings that reported the sensitivity and specificity of sensor technologies to detect cardiac arrest on human or animal subjects. (Prospero# CRD42021267797). We screened 1666 articles and included four publications examining sensor technologies. One tested the performance of a physical sensor on human participants in simulated CA, one tested performance on audio recordings of patients in cardiac arrest, and two utilized a hybrid design for testing including human participants and ECG databases. Three of the devices were wearable and one was an audio detection algorithm utilizing household smart technologies. Real-world testing was limited in all studies. Sensitivity and specificity for the sensors ranged from 97.2 to 100% and 90.3 to 99.9%, respectively. All included studies had a medium/high risk of bias, with 2/4 having a high risk of bias. Sensor technologies show promise for cardiac arrest detection. However, current evidence is sparse and of high risk of bias. Small sample sizes and databases with low external validity limit the generalizability of findings.
Recent developments have illustrated the feasibility of scalable out-of hospital cardiac arrest (OHCA) detection using consumer-wearable products. While initial evidence is promising, the real-world effectiveness of these technologies is unproven and design decisions to minimize false positives may constrain clinical impact. To support the real-world evaluation of these technologies, we analyzed registry data and evaluated strategies for a clinical trial. We analyzed Emergency Medical Services (EMS)-treated and EMS-untreated cases in the British Columbia Cardiac Arrest Registry (2019-2020) who may have benefitted from cardiac arrest detection. Within strata formed by Age (0-35, 36-55, 56-65, 65+) and Sex, we estimated strata-specific treatment effects from recognition and calculated the required sample sizes for a set of potential primary clinical outcomes for a trial (survival to hospital discharge, initial shockable cardiac rhythm, EMS treatment). We compared this with population incidence to inform prospective recruitment requirements. Within a population-at-risk of 9,739,356, 11,382 sentinel cases met criteria for inclusion. Strata-specific incidence ranged from 18.3 per 100,000 to 395 per 100,000. The most statistically efficient subgroup for a survival outcome was Males aged 56-65 (171,676 needed, total). For a trial outcome of EMS treatment or initial shockable rhythm, Males over 65 were the most efficient subgroup within which to test the intervention (7,608 and 66,962 needed, total respectively). A prospective trial of OHCA detection technologies will require large recruitment targets. Subgroups with the highest estimated treatment effect are not those with the highest incidence. Large trials in the general population will require multiple centers and innovative recruitment strategies that may be aided by partnership with industry.
Conventional cardiopulmonary resuscitation (CPR) is guided primarily by process metrics that do not directly quantify cerebral hemodynamics or perfusion. Near-infrared spectroscopy (NIRS) provides continuous, non-invasive monitoring of regional tissue oxygenation and has emerged as a candidate modality for physiologic feedback during low-flow states. However, CPR applications vary across devices and signal processing. This scoping review maps how NIRS has been implemented during conventional CPR in humans and porcine models, with emphasis on instrumentation characteristics, signal processing, acquisition bandwidth, artifact handling, physiologic associations, and feasibility constraints. From 1048 records, 39 studies met the inclusion criteria. Most used forehead-based cerebral rSO2 monitoring (30/39). Rising cerebral oxygenation trajectories were consistently associated with return of spontaneous circulation (ROSC). In contrast, persistently low or non-increasing patterns were associated with non-ROSC, and absolute thresholds varied substantially across devices and studies. A minority of investigations derived compression-rate or waveform features from hemoglobin signals. Feasibility findings emphasized rapid probe placement without interrupting compressions but highlighted motion artifact, workflow constraints, and incomplete acquisition reporting. Overall, during conventional CPR, NIRS primarily serves as a dynamic monitor of oxygenation trends rather than a validated prognostic tool. Emerging waveform-based and hemodynamic analyses suggest the potential to evaluate CPR efficiency using perfusion-responsive optical features.